Visit us at CPhI Europe, October 28–30 at Messe Frankfurt, and experience Olon as one unified, fully integrated global partner.
Olon brings together deep expertise in chemical synthesis, high-potency (HPAPI) development, bioconjugation and ADC technologies, and fermentation, providing end-to-end solutions that seamlessly support projects from early development through to commercial manufacturing.
One Brand. One Story. Many Capabilities.
At CPhI Frankfurt, Olon will present a single, global identity—a clean, white-and-blue booth, a concise capability map, and straightforward infographics that make it easy to grasp “Olon at a glance.” The intent is purposeful: in a meeting-packed show, attendees need a crisp story and fast orientation.
What you’ll see at the booth
- A unified global presence: one brand with harmonized messaging.
- A capabilities reel (running on-loop) that highlights technology depth, site footprint, and engagement model.
- A dedicated meeting room plus open conversation space so your team can connect quickly and keep moving.
Why the “Contract Service Zone” this Year at CPHI, and Why Now?
That move reflects how customers increasingly engage Olon: for full-scope development and manufacturing, not just ingredients. Positioning in this hall also makes it easier for partners to locate the services that align to clinical and commercial goals (including HPAPI, bioconjugation/ADCs, and fermentation).
What’s New to Talk About
There is plenty to discuss when you visit the Olon booth this year:
- Investment momentum: Ongoing capital investments across our network, especially in HPAPI and bioconjugation, to expand capacity and strengthen end-to-end programs.
- E2E integration: From process development through validation and commercial manufacturing for both chemical and biological modalities.
- Execution at scale: A global infrastructure designed to deliver quality and speed under evolving regulatory demands.
Translation: if your 2026–2027 pipeline includes high-potency or ADC programs, this is a timely conversation to have at CPhI.
U.S. or Europe? Yes.
Geopolitics and supply-chain scrutiny have raised the bar for local presence. With an Olon location operating inside USA and part of our global Olon network of facilities, sponsors can benefit from U.S.-based execution while tapping European depth in fermentation, complex chemistry, and bioconjugation. The result is a single partner that speaks the languages of innovator biotech and large pharma alike, without fragmentation.
Who Should Stop By
- Innovator biotechs seeking a nimble CDMO that scales with the asset.
- Large pharma consolidating suppliers around HPAPI, ADCs, and fermentation.
- Program leaders who value short, on-point conversations that lead to actionable next steps.
On-Booth Experience (Keep It Efficient)
We know CPhI calendars are packed in 20–25 minute slots. Our booth is organized to make every minute count, orientation in seconds, decision-maker access, and a clear path to “what happens next.” On October 29, we’ll host a private, invitation-only partner reception at the booth, kept intentionally understated and secure to respect venue guidelines and our guests’ schedules.
- Event: CPhI Europe (CPhI Frankfurt)
- Dates: October 28–30, 2025
- Venue: Messe Frankfurt (Frankfurt am Main, Germany)
- Where: Stand 5.0 D92
Let’s Build the Future of Healthcare—Together
We have tradition, expertise, technology, and capabilities and now we’re presenting them as one global picture. Come take that new picture of Olon in Frankfurt, and let’s map your next milestones, from development through to commercial supply.
Book a meeting: Tell us your preferred day/time at CPhI, your asset phase (preclinical/clinical/commercial), and whether your focus is HPAPI, ADC/bioconjugation, fermentation, or small-molecule CDMO services. We’ll pair you with the right technical leads.